Aquestive Therapeutics to Report Fourth Quarter 2023 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET



WARREN, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced that it will report results for the fourth quarter ended December 31, 2023 and provide an update on recent developments in its business after market close on Tuesday, March 5, 2024.

Management will host a conference call for investors at 8:00 a.m. ET on Wednesday, March 6, 2024. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.

A live webcast of the call will be available on Aquestive’s website at: Fourth Quarter 2023 Earnings Call

Following the call, a replay of the webcast will be available on the Investors section of the Company’s website at The webcast will be archived for 30 days.

About Aquestive Therapeutics
Aquestive is a pharmaceutical …

Full story available on


Leave a Reply

Your email address will not be published. Required fields are marked *